Company Registration No. 08306790 (England and Wales)
EJ PHARMCARE LIMITED
Unaudited accounts
for the year ended 30 November 2020
EJ PHARMCARE LIMITED
Unaudited accounts
Contents
EJ PHARMCARE LIMITED
Company Information
for the year ended 30 November 2020
Director
Evelyne Tifuh Jato
Company Number
08306790 (England and Wales)
Registered Office
27 ALEXANDRA DRIVE
LONDON
SE19 1AW
Accountants
SA Accountancy Practice
Suit 201, Equitable House
10 Woolwich New Road
Woolwich
London
SE18 6AB
EJ PHARMCARE LIMITED
Statement of financial position
as at 30 November 2020
Cash at bank and in hand
2,589
933
Creditors: amounts falling due within one year
(31,663)
(30,550)
Net current liabilities
(29,074)
(28,133)
Net liabilities
(25,074)
(24,133)
Called up share capital
100
100
Profit and loss account
(25,174)
(24,233)
Shareholders' funds
(25,074)
(24,133)
For the year ending 30 November 2020 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 August 2021 and were signed on its behalf by
Evelyne Tifuh Jato
Director
Company Registration No. 08306790
EJ PHARMCARE LIMITED
Notes to the Accounts
for the year ended 30 November 2020
EJ PHARMCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 08306790. The registered office is 27 ALEXANDRA DRIVE, LONDON, SE19 1AW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Motor vehicles
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 December 2019
1,200
550
1,750
At 30 November 2020
1,200
550
1,750
At 1 December 2019
1,200
550
1,750
At 30 November 2020
1,200
550
1,750
5
Investments
Other investments
Valuation at 1 December 2019
4,000
Valuation at 30 November 2020
4,000
EJ PHARMCARE LIMITED
Notes to the Accounts
for the year ended 30 November 2020
6
Debtors: amounts falling due within one year
2020
2019
7
Creditors: amounts falling due within one year
2020
2019
Trade creditors
2,458
1,839
Loans from directors
29,205
27,751
8
Average number of employees
During the year the average number of employees was 0 (2019: 0).
